Worldwide Webinar Series:

Impact of Modeling & Simulation in Drug Development

Rosa’s Worldwide Webinar Series fosters the adoption of modeling and simulation by informing a broad audience about the strategic impact it can have on all aspects of research and development.

Since its inception in 2011, this complimentary, monthly series has featured select speakers from academia, industry, Rosa client companies, and Rosa itself. The series has drawn many thousands of attendees worldwide from all drug development disciplines.

Sign up to receive Webinar and QSP News Alerts

Date Presenter / Topic Register

Sergio Iadevaia, PhD
Scientific Director QSP, Pharmacometrics and Data Analysis at Takeda

Development of a QSP Platform to Quantify Benefits of DAAO Inhibition in Schizophrenia

Jonathan Allen, PhD
Computational Scientist at ATOM

tbd

Stacey Tannenbaum, PhD, FISoP
Senior Director, Pharmacometrics US Clinical Pharmacology and Exploratory Development, Astellas Pharma, Northbrook, IL

tbd

Jim Faeder, PhD
Associate Professor at University of Pittsburgh

tbd

Youfang Cao, PhD
Senior Scientist, Quantitative Pharmacology and Pharmacometrics at Merck

tbd

"In an evolving field such as QSP, the webinars allow us to keep ahead with that critical edge of knowledge."
—Rebecca A. Baillie, PhD, Principal Scientist & Chief of Staff